ACSR in POZ Article July-August 2019
POZ “Viral Control” Q & A with Dr. Robert Yarchoan, Director of the Office of HIV and AIDS Malignancy at the U.S. National Cancer Institute. (READ MORE)
POZ “Viral Control” Q & A with Dr. Robert Yarchoan, Director of the Office of HIV and AIDS Malignancy at the U.S. National Cancer Institute. (READ MORE)
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October …
The fellowship program was established to encourage and foster the development of new and junior clinical investigators at our domestic and international sites to pursue careers in clinical research trials …
For more information about this potential funding opportunity, please check out the Office of HIV and AIDS Malignancy’s presentation of the FOA Concept to the Board of Scientific Advisors on …
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October …
Come Visit Us at ASH 2017 from December 9-12 held at the Georgia World Congress Center Booth #1740
The HIV and AIDS Malignancy Branch (HAMB) is seeking a tenure-eligible or tenure-track investigator in the field of HIV–related malignancies or viral oncogenesis. (READ MORE)
The Conquer Cancer Foundation (CCF) of ASCO is accepting applications for the inaugural 2018 Global Oncology Young Investigator Award (YIA). The one-year grant provides research funding to early-career investigators to …
Yanik EL, Kaunitz GJ, Cottrell TR, Succaria F, McMiller TL, Ascierto ML, Esandrio J, Xu H, Ogurtsova A, Cornish T, Lipson EJ, Topalian SL, Engels EA, Taube JM. Association of …
Yakovleva A, Plieskatt JL, Jensen S, Humeida R, Lang J, et al. (2017) Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue. PLOS ONE …